Improving HPV vaccination rates in rural communities
Official title: ReMARk: A Multi-level Intervention Addressing Disparities in Rural HPV-related Cancer Prevention: Part 3- Evaluation
Run by University of Florida · NCT06535139 · Data updated 2026-11-12
This study is testing different ways to help parents in rural North Central Florida get their kids aged 9 to 12 vaccinated against HPV to see if it can improve vaccination rates.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 8 Years to 99 Years |
| Sex | All |
| Enrollment | 4630 (estimated) |
| Sponsor | University of Florida Academic / other |
| Locations | 1 site (Gainesville, Florida) |
| Status | Recruiting |
| Started | December 9, 2024 |
| Main results expected | May 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | October 8, 2026 |
| Trial ID | NCT06535139 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adolescents aged 9 to 12 years who have not yet received both doses of the HPV vaccine and have visited a participating clinic in the past year.
✕Probably not a fit
Patients outside the age range of 8 to 12 years or those whose providers are unwilling to consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance the effectiveness of HPV vaccine recommendations in rural North Central Florida by evaluating various implementation strategies. It focuses on parent-targeted motivational aids and community healthcare access assistance, assessing their clinical and cost-effectiveness. The study will also analyze how patient-level factors, such as age and social vulnerability, influence the effectiveness of these strategies. By addressing barriers faced by clinicians, parents, and healthcare access, the study seeks to improve vaccination rates among 9- to 12-year-olds.
Why it matters
Potential benefit: If successful, this study could significantly increase HPV vaccination rates in rural communities, reducing cancer disparities.
How similar studies have gone: Other studies have shown success in using similar community-targeted approaches to improve vaccination rates, indicating that this method is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents Age 8- to 12-years-old Visited participating clinic in past year or during study No records of receiving both HPV vaccine doses * Providers Provide 9- to 12-year-old patients primary care Practice at a participating clinic Exclusion Criteria: * Adolescents Out of age range * Providers Unwilling to consent
Where it's running
-
University of Florida
Gainesville, Florida, United States Recruiting
Study contacts
- Principal investigator: Stephanie Staras, PhD — University of Florida
- Study coordinator: Stephanie Staras, PhD
- Email: sstaras@ufl.edu
- Phone: 352-294-8299
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using e-Bug classroom education to boost HPV vaccine consent in a middle school
This project tests whether using the e-Bug classroom education in a French middle school helps increase parental consent and HPV vaccination rates among eligible students during the 2023–2025 school campaigns.
-
Transtheoretical Model education to improve HPV vaccine knowledge and readiness in first-year nursing students
This program will try a Transtheoretical Model-based education to see if it increases first-year nursing students' HPV knowledge and makes them more ready to get the HPV vaccine.
-
Evaluating the Gardasil-9 HPV vaccine in adults with HIV
This study is testing how well the Gardasil-9 HPV vaccine works for adults with well-controlled HIV to see if their immune response is similar to those without HIV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.